Peri-Conceptional A1C and Risk of Serious Adverse Pregnancy Outcome in 933 Women With Type 1 Diabetes
Open accessThe DOI matches its Crossref record; 13 of the 14 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: To study the association between peri-conceptional A1C and serious adverse pregnancy outcome (congenital malformations and perinatal mortality). RESEARCH DESIGN AND METHODS: Prospective data were collected in 933 singleton pregnancies complicated by type 1 diabetes. RESULTS: The risk of serious adverse outcome at different A1C levels was compared with the background population. The risk was significantly higher when peri-conceptional A1C exceeded 6.9%, and the risk tended to increase gradually with increasing A1C. Women with A1C exceeding 10.4% had a very high risk of 16%. Congenital malformation rate increased significantly at A1C above 10.4%, whereas perinatal mortality was increased even at A1C below 6.9%. CONCLUSIONS: These results support recent guidelines of preconceptional A1C levels <7% in women with type 1 diabetes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Observational studies in preexisting diabetes and pregnancy show the lowest rates of adverse fetal outcomes in association with A1C <6-6.5% (<42-48 mmol/mol) early in gestation (4-6,40).”
From 15. Management of Diabetes in Pregnancy: Standards of Care in Diabetes—2024 (2024) · cites this paper as [4]
Experimental — accuracy not yet measuredIn the citing paper
“It has, however, also been reported (20) that there is a stable degree of anomaly risk of 3.9% to 5.0% with a periconceptional HbA1C of up to 10.4%”
From Diabetes and Pregnancy: An Endocrine Society Clinical Practice Guideline (2013) · cites this paper as [20]
In the citing paper
“with this risk then climbing to 10.9% if the HbA1C is 10.4% or higher.”
From Diabetes and Pregnancy: An Endocrine Society Clinical Practice Guideline (2013) · cites this paper as [20]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Evers, I. M., de Valk, H. W., & Visser, G. H. A. (2004) · BMJ · doi:10.1136/bmj.38043.583160.ee · Cited by 775
Miller, E., Hare, J. W., Cloherty, J. P., Dunn, P. J., Gleason, R. E., Soeldner, J. S., & Kitzmiller, J. L. (1981) · New England Journal of Medicine · doi:10.1056/nejm198105283042204 · Cited by 665
Outcomes in Type 1 Diabetic Pregnancies
Jensen, D. M., Damm, P., Moelsted-Pedersen, L., Ovesen, P., Westergaard, J. G., Moeller, M., & Beck-Nielsen, H. (2004) · Diabetes Care · doi:10.2337/diacare.27.12.2819 · Cited by 486 · cited 6×
“The central data registration was performed by Susanne Joergensen, Danish Diabetes Association.”
BackgroundMethodInfluentialSelf-citationManaging preexisting diabetes for pregnancy
Kitzmiller, J. L., Block, J. M., Brown, F. M., Catalano, P. M., Conway, D. L., Coustan, D. R., Gunderson, E. P., Herman, W. H., Hoffman, L. D., Inturrisi, M., et al. (2008) · Diabetes Care · doi:10.2337/dc08-9020 · Cited by 476
HbA1c levels are significantly lower in early and late pregnancy
Nielsen, L. R., Ekbom, P., Damm, P., Glümer, C., Frandsen, M. M., Jensen, D. M., & Mathiesen, E. R. (2004) · Diabetes Care · doi:10.2337/diacare.27.5.1200 · Cited by 331 · cited 1×
“We used a reference based on A1C values outside pregnancy, and although A1C has been shown to decline during pregnancy (12), this is not until later stages of gestation.”
MethodSelf-citationSuhonen, L., Hiilesmaa, V., & Teramo, K. (2000) · Diabetologia · doi:10.1007/s001250050010 · Cited by 302 · cited 1×
“(9) studied 709 offspring of type 1 diabetic women and found an increased risk of congenital mal-”
BackgroundPregnancy outcomes in the Diabetes Control and Complications Trial
(1996) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(96)70683-x · Cited by 278
Prepregnancy Care and Pregnancy Outcomes in Women With Type 1 Diabetes
Temple, R. C., Aldridge, V. J., & Murphy, H. R. (2006) · Diabetes Care · doi:10.2337/dc05-2265 · Cited by 184
Hanson, U., Persson, B., & Thunell, S. (1990) · Diabetologia · doi:10.1007/bf00401047 · Cited by 176 · cited 1×
“(7) examined 532 women with type 1 diabetes and 222 control subjects, demonstrating a significant increase in congenital malformation and spontaneous abortion at A1C z scores 8.”
Temple, R., Aldridge, V., Greenwood, R., Heyburn, P., Sampson, M., & Stanley, K. (2002) · BMJ · doi:10.1136/bmj.325.7375.1275 · Cited by 152
Cited by
Items 101–200 of 231
Negrato, C. A., Marques, P. R., Leite, H. B., Torigoe, C. N., Silva, B. F., Costa, K., Kamei, J. M., Zampa, C. L., Toni, A. C. R. G., Pereira, I. C. G. S., et al. (2022) · Archives of Endocrinology and Metabolism · doi:10.20945/2359-3997000000521 · Cited by 14
“00% increase in the risk of fetal malformations (23).”
BackgroundAMD-Annals Study Group, Scavini, M., Rossi, M. C., Scardapane, M., Nicolucci, A., Manicardi, V., Russo, G. T., Bartolo, P. D., Giorda, C. B., Musacchio, N., et al. (2017) · Acta Diabetologica · doi:10.1007/s00592-017-1076-9 · Cited by 12
Hauffe, F., Fauzan, R., Schohe, A., Scholle, D., Sedlacek, L., Scherer, K., Klapp, C., Ramsauer, B., Henrich, W., Schlembach, D., et al. (2020) · Diabetic Medicine · doi:10.1111/dme.14350 · Cited by 11
Glucose Treatment Targets in Pregnancy - A Review of Evidence and Guidelines
Byford, A. R., Forbes, K. A., & SCOTT, E. M. (2022) · Current Diabetes Reviews · doi:10.2174/1573399818666220422083935 · Cited by 13
Song, Y., Zhai, X., Bai, Y., Liu, C., & Zhang, L. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1218602 · Cited by 17
Time trends in pregnancy-related outcomes among women with type 1 diabetes mellitus, 2004–2017
Helman, S., James-Todd, T. M., Wang, Z., Bellavia, A., Wyckoff, J., Serdy, S., Halprin, E., O’Brien, K., Takoudes, T. C., Gupta, M., et al. (2020) · Journal of Perinatology · doi:10.1038/s41372-020-0698-x · Cited by 13
Assessment of the effect of pregnancy planning in women with type 1 diabetes treated by insulin pump
Mourou, L., Vallone, V., Vania, E., Galasso, S., Brunet, C., Fuchs, F., Boscari, F., Cavallin, F., Bruttomesso, D., & Renard, É. (2020) · Acta Diabetologica · doi:10.1007/s00592-020-01620-7 · Cited by 12
Dornhorst, A., & Banerjee, A. (2010) · Wiley eBooks · doi:10.1002/9781444324808.ch53 · Cited by 14
Sotagliflozin: a combined SGLT1/SGLT2 inhibitor to treat diabetes
Rendell, M. (2018) · Expert Review of Endocrinology & Metabolism · doi:10.1080/17446651.2018.1537779 · Cited by 10
“Pregnancy in women with diabetes requires continual attempts to normalize glucose levels, and, before conception, the goal is to keep Hba1c as close to normal as possible in order to prevent excess spontaneous abortions and major congenital malformations [29,30].”
BackgroundGestational Diabetes and Type 2 Diabetes During Pregnancy
Mukerji, G., Bacon, S., & Feig, D. S. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-814823-5.00022-2 · Cited by 13
Goldberg, A., Ursing, C., Ekéus, C., & Wiberg‐Itzel, E. (2021) · Primary care diabetes · doi:10.1016/j.pcd.2021.08.003 · Cited by 11
Perinatal outcomes in pregnancies complicated by type 1 diabetes mellitus
Xu, Q., Lü, J., Hu, J., Ge, Z., Zhu, D., & Bi, Y. (2020) · Gynecological Endocrinology · doi:10.1080/09513590.2020.1727432 · Cited by 9
Disney, E. A., Sanders, J. N., Turok, D. K., & Gawron, L. M. (2020) · Women s Health Reports · doi:10.1089/whr.2020.0042 · Cited by 9
“4% at conception.(5) Data support preconception care, including optimizing glycemic control before conception with HbA1c <6.”
BackgroundRasmussen, B., Skouteris, H., Berg, M., Nagle, C., Morris, H., Nankervis, A. J., & Sparud‐Lundin, C. (2014) · Women and Birth · doi:10.1016/j.wombi.2014.11.001 · Cited by 9
“Exclusive breastfeeding infants of T1DM mothers is an important component of optimising neonatal outcomes.(19)”
BackgroundLarsen, M. D., Jensen, D. M., Fedder, J., Jølving, L. R., & Nørgård, B. M. (2020) · Diabetologia · doi:10.1007/s00125-020-05193-6 · Cited by 10
Self-citationPreconception counseling in women with diabetes: the SEARCH for diabetes in youth study
Roberts, A. J., Sauder, K., Stafford, J. M., Malik, F. S., Pihoker, C., Boghossian, N. S., Ehrlich, S., Pettitt, D. J., Dabelea, D., Bellatorre, A., et al. (2023) · Clinical Diabetes · doi:10.2337/cd22-0030 · Cited by 7
Quality of Medical Care in Diabetic Women Undergoing Fertility Treatment
Riskin‐Mashiah, S., & Auslander, R. (2011) · Diabetes Care · doi:10.2337/dc11-0966 · Cited by 8
“A large Danish study (10) among type 1 diabetic patients shows that only 30.”
BackgroundEfficacy and safety of sotagliflozin in treating diabetes type 1
Rendell, M. (2017) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2017.1414801 · Cited by 11
“The guidelines require that before pregnancy target A1C should be as close to normal as possible without significant hypoglycemia in order to prevent excess spontaneous abortions and major congenital malformations [31,32].”
BackgroundSkajaa, T., Kampmann, U., Fuglsang, J., & Ovesen, P. (2020) · Journal of Diabetes · doi:10.1111/1753-0407.13070 · Cited by 9
“Diabetes duration (years) 11 (4-19) 17 (9-23) 14 (8-22) 14 (10-17)”
Self-citationMcCance, D. R., & Cassidy, L. (2024) · Wiley eBooks · doi:10.1002/9781119697473.ch71 · Cited by 9
Rotem, R. S., Weisskopf, M. G., Bateman, B. T., Huybrechts, K. F., & Hernández–Díaz, S. (2024) · Human Reproduction · doi:10.1093/humrep/deae233 · Cited by 7
Chen, H., Tan, Q., Lai, S., Mai, H., & Wang, D. (2024) · Scientific Reports · doi:10.1038/s41598-024-78679-7 · Cited by 8
“In women with preexisting diabetes, early pregnancy HbA1c level exhibit a direct correlation with pregnancy outcomes 35–37 .”
BackgroundTherapeutic management of type 1 diabetes before and during pregnancy
Mathiesen, E. R., Ringholm, L., & Damm, P. (2011) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2011.540388 · Cited by 8
“9% (new values, below 3 SD) [16] and supplementation with at least 400 μg folic acid before pregnancy [14] are recommended to improve the outcome of pregnancy and the health of the newborn.”
BackgroundSelf-citationDiabetic Pregnancy and Fetal Consequences
Teramo, K. A. (2014) · NeoReviews · doi:10.1542/neo.15-3-e83 · Cited by 7
Morlando, M., Savoia, F., Conte, A. M., Schiattarella, A., Verde, M. L., Petrizzo, M., Carpentieri, M., Capristo, C., Esposito, K., & Colacurci, N. (2021) · Journal of Diabetes Research · doi:10.1155/2021/9959606 · Cited by 13
“Given the evidence of an increased risk of congenital abnormalities, especially anencephaly, microcephaly, and congenital heart disease, directly proportional to hemoglobin A1C during the first 10 weeks of pregnancy, a strict glycemic control is strongly encouraged [24].”
BackgroundPregnancy outcome with maternal HNF1B gene mutations and 17q12 deletions
Morton, A., Li, L., & Wilson, C. L. (2022) · Obstetric Medicine · doi:10.1177/1753495x221109734 · Cited by 7
“Poor maternal diabetes control in the first trimester is associated with an increased risk of fetal malformations and miscarriage.(30,31) Poor maternal diabetes control during pregnancy is associated with an increased risk of stillbirth, fetal macrosomia, birth injury, neonatal hypoglycaemia and jaundice.”
BackgroundNeu, J. (2010) · Yearbook of Neonatal and Perinatal Medicine · doi:10.1016/s8756-5005(09)79153-x · Cited by 7
Segerer, H., Bührer, C., Kapellen, T. M., Mattern, E., Ramsauer, B., SOMVILLE, T., & Trotter, A. (2018) · Zeitschrift für Geburtshilfe und Neonatologie · doi:10.1055/a-0628-0873 · Cited by 7
“Diabetes Care 2009; 32: 1046–1048 [2] Hammouda SA, Hakeem R. Role of HbA1c in predicting risk for congenital malformations.”
BackgroundInfluentialClosed-loop insulin delivery in adults with type 1 diabetes
Kumareswaran, K. (2012) · Apollo (University of Cambridge) · doi:10.17863/cam.16644 · Cited by 7
“4%.[208] However, interpretation of HbA1c is limited during pregnancy due to the dynamic changes that occur to red blood cells, including increased cell turnover and erythropoietin levels, and the effects of haemodilution with increasing gestation.”
The Quality of Periconception Medical Care in Women With Diabetes Needs Improvement
Riskin‐Mashiah, S., Auslander, R., & Almog, R. (2013) · Diabetes Care · doi:10.2337/dc13-2143 · Cited by 6
“For example, a French multicenter survey (10) and a large Danish study (11) found that women with higher first trimester A1C had increased risk for adverse perinatal outcome.”
BackgroundAung, N. L. (2023) · Clinical Diabetes · doi:10.2337/cd23-0084 · Cited by 7
Is not testing a major change in clinical practice an ethical dilemma?
Della Forster, A., Moorhead, A. M., Jacobs, S. E., Amir, L. H., Walker, S. P., McEgan, K. M., Opie, G. F., McNamara, C., & Ford, R. (2011) · Midwifery · doi:10.1016/j.midw.2010.03.003 · Cited by 6
Harreiter, J., & Kautzky‐Willer, A. (2016) · Wiener klinische Wochenschrift Education · doi:10.1007/s11812-016-0078-9 · Cited by 6
Gravidität bei vorbestehendem Diabetes (Update 2019)
Kautzky‐Willer, A., Harreiter, J., Winhofer-Stöckl, Y., Weitgasser, R., & Lechleitner, M. (2019) · Wiener klinische Wochenschrift · doi:10.1007/s00508-019-1456-y · Cited by 6
ADIPS position paper on pre‐existing diabetes and pregnancy
Rudland, V. L., Price, S., & Callaway, L. K. (2020) · Australian and New Zealand Journal of Obstetrics and Gynaecology · doi:10.1111/ajo.13266 · Cited by 6
Techniques of monitoring blood glucose during pregnancy for women with pre-existing diabetes
Moy, F. M., Ray, A., & Buckley, B. S. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009613 · Cited by 6
Type 1 Diabetes and Pregnancy: Challenges in Glycemic Control and Maternal–Fetal Outcomes
Apata, T., Samuel, D., Valle, L., & Crimmins, S. D. (2024) · Seminars in Reproductive Medicine · doi:10.1055/s-0044-1791704 · Cited by 6
“34,40 43 PregnanciescharacterizedbyhemoglobinA1c (HbA1c) levels at or below 6% demonstratea baseline anomaly risk that is comparable to the general population, although in somestudiestherewasaslight riskevenatalevelof5.”
Glycemic Control and Risk of Congenital Malformations in Women With Type 1 Diabetes
Thorius, I. H., Petersen, J., Husemoen, L. L. N., Alibegovic, A. C., Gall, M.-A., Damm, P., & Mathiesen, E. R. (2024) · Obstetrics and Gynecology · doi:10.1097/aog.0000000000005722 · Cited by 6
“5,6 During early pregnancy, Hb A 1C levels decrease as part of normal physiologic changes.”
Self-citationRaffel, L. J., & Goodarzi, M. O. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-383834-6.00090-2 · Cited by 6
Aung, N. L. (2024) · Clinical Diabetes · doi:10.2337/cd24-0009 · Cited by 6
Lemaître, M., Faiz, K., Baudoux, F., Subtil, D., & Vambergue, A. (2022) · Diabetes and Vascular Disease Research · doi:10.1177/14791641221136837 · Cited by 5
Soriano, L. C., Rodríguez, L. A. G., Brodovicz, K. G., Massó-González, E. L., Bartels, D. B., & Hernández–Díaz, S. (2018) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.4553 · Cited by 5
“For instance, the risk of birth defects rises as glycosylated hemoglobin (HbA1C) levels increase above 6%.(11-14) The National Institute for Health and Clinical Excellence guidelines on the management of diabetes encourage women of childbearing age with diabetes to avoid unplanned pregnancies and to monitor blood gluc…”
BackgroundMissed opportunities for appropriate postpartum care in women with pregestational diabetes
Riskin‐Mashiah, S., & Almog, R. (2015) · The Journal of Maternal-Fetal & Neonatal Medicine · doi:10.3109/14767058.2015.1062871 · Cited by 5
“Most studies in the past evaluated mainly periconception glycemic control and pregnancy outcome [3,6,7].”
BackgroundGarey, C., Lynn, J., Sabino, A. F., Hughes, A. S., & McAuliffe‐Fogarty, A. H. (2020) · Gynecological Endocrinology · doi:10.1080/09513590.2020.1749998 · Cited by 5
Diabetes Mellitus and Pregnancy
Szmuilowicz, E. D., Niznik, C. M., & Metzger, B. E. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.64972-3 · Cited by 5
Ryan, L. W. K., Weiying, L., Wright, A., & Tan, L. (2025) · Cambridge University Press eBooks · doi:10.1017/9781009507189 · Cited by 4
Kattner, E., Maier, F., Gonser, M., Schneider, K. T. M., Kainer, F., SOMVILLE, T., Vetter, K. J., Schäfer-Graf, U. M., Schunk, K., Mandl, M., et al. (2011) · Monatsschrift Kinderheilkunde · doi:10.1007/s00112-010-2276-3 · Cited by 4
Zarrin, Y., Bakhteyari, A., Nikpour, P., Mostafavi, F. S., Eskandari, N., Matinfar, M., & Aboutorabi, R. (2020) · Journal of Reproduction & Infertility · Cited by 4
Jeraiby, M. (2021) · International Journal of General Medicine · doi:10.2147/ijgm.s335914 · Cited by 5
“The guideline recommended for the management of preconception women with T1DM is to have glycated hemoglobin A1C (A1C) greater than 7% and as close to 6% as possible without noticeable hypoglycemia.(14) Many plans have been made to set up preconception care for women with T1DM in order to reduce health risks for mothe…”
BackgroundHoek-Hogchem, R., Bovenberg, S. A., Dekker, P., Birnie, E., Veeze, H. J., Duvekot, H., Galjaard, S., & Aanstoot, H. (2022) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/a-1797-8317 · Cited by 4
“5%) lower the risk of congenital anomalies [9].”
BackgroundOgassavara, J., Dualib, P. M., Mattar, R., Dib, S. A., & de Almeida-Pititto, B. (2023) · Archives of Endocrinology and Metabolism · doi:10.20945/2359-4292-2022-0483 · Cited by 7
“Intensive glycemic control before conception and during pregnancy is essential to reduce the occurrence of these adverse outcomes (16-21).”
BackgroundKautzky‐Willer, A., Harreiter, J., Weitgasser, R., & Lechleitner, M. (2016) · Wiener klinische Wochenschrift · doi:10.1007/s00508-015-0943-z · Cited by 6
(2016) · Actualidad Contable FACES · Cited by 4
Ringholm, L., Ásbjörnsdóttir, B., Andersen, H. U., Damm, P., & Mathiesen, E. R. (2017) · Springer eBooks · doi:10.1007/978-3-319-56440-1_30 · Cited by 3
Self-citationGravidität bei vorbestehendem Diabetes (Update 2023)
Kautzky‐Willer, A., Winhofer, Y., Weitgasser, R., Lechleitner, M., & Harreiter, J. (2023) · Wiener klinische Wochenschrift · doi:10.1007/s00508-023-02188-2 · Cited by 4
“Um Missbildungen und Aborte zu vermeiden soll der Glukosestoffwechsel mit einem HbA1c< 6,5%, zumindest aber unter 7% bereits bei Kinderwunsch optimiert sein [7, 9].”
BackgroundMahmood, K. S., & Al-Rasol, E. A. A. (2022) · Medical Journal of Babylon · doi:10.4103/mjbl.mjbl_53_22 · Cited by 3
Standardy Polskiego Towarzystwa Ginekologów i Położników postępowania u kobiet z cukrzycą
Wender-Ożegowska, E., Bomba-Opon, D. A., Brązert, J., Celewicz, Z., Czajkowski, K., Gutaj, P., Malinowska-Polubiec, A., Zawiejska, A., & Wielgoś, M. (2017) · Ginekologia i Perinatologia Praktyczna · Cited by 18
Yin, Y., Bei, L., Sun, L., Ye, J., & Xu, M. (2022) · Journal of Obstetrics and Gynaecology · doi:10.1080/01443615.2022.2049723 · Cited by 3
“For example, newborns of women with type 1 diabetic have higher perinatal mortality (Jensen et al. 2009; Landon et al. 2009; Garc ıa-Patterson et al. 2010).”
BackgroundThe importance of treating mild hyperglycemia in pregnant women with diabetes
Kim, K. (2018) · The Korean Journal of Internal Medicine · doi:10.3904/kjim.2018.351 · Cited by 3
Zhang, M., Wan, S., Yan, J., & Yang, H. (2025) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-025-01742-4 · Cited by 3
“For T2DM pregnant women, the uncontrolled hyperglycemia during pregnancy not only influenced the metabolic condition of maternal-fetus, but also enhanced the risks of increased birthweight, congenital malformation, and even perinatal mortality [1, 2].”
NICE 's latest guidelines on diabetes in pregnancy: getting the balance right
Holt, H. (2015) · Practical Diabetes · doi:10.1002/pdi.1930 · Cited by 2
Zolton, J. R., Sjaarda, L. A., Mumford, S. L., Holland, T. L., Kim, K., Flannagan, K. S. J., Yisahak, S. F., Hinkle, S. N., Connell, M. T., White, M. V., et al. (2022) · F&S Reports · doi:10.1016/j.xfre.2022.01.002 · Cited by 2
“Elevations of A1c concentrations above the criteria diagnostic for diabetes in pregnant women with poorly controlled diabetes have been linked to early pregnancy loss (2, 3), stillbirth (2), and congenital anomalies (4).”
BackgroundDiabetes mellitus und Schwangerschaft
Schaefer-Graf, U. M., Kautzky‐Willer, A., & Groten, T. (2023) · Springer Reference Medizin · doi:10.1007/978-3-662-44369-9_26-2 · Cited by 2
Tamura, R. K., Kodani, N., Itoh, A., Meguro, S., Kajio, H., & Itoh, H. (2024) · Diabetology International · doi:10.1007/s13340-024-00716-7 · Cited by 2
“Peri-conception hyperglycemia increases the risk of congenital anomalies and peri-natal mortality [1–3].”
Akute metabolische Entgleisungen
Maier, R. F. (2011) · Springer eBooks · doi:10.1007/978-3-642-01069-9_11 · Cited by 2
Kautzky‐Willer, A., Weitgasser, R., & Lechleitner, M. (2012) · Wiener klinische Wochenschrift · doi:10.1007/s00508-012-0285-z · Cited by 2
Sieradzki, J., Cyganek, K., Cypryk, K., Wender-Ożegowska, E., Skoczylas, K., Runzis, S., & Shin, J. H. (2018) · Clinical Diabetology · doi:10.5603/dk.2018.0009 · Cited by 2
“The relationship between glucose control before conception and the incidence of miscarriage and congenital malformations is well established [6, 9, 10].”
BackgroundAdvances in pharmacological treatment of type 1 diabetes during pregnancy
Patti, A. M., Giglio, R. V., Pafili, K., Rizzo, M., & Παπάνας, Ν. (2019) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2019.1593372 · Cited by 2
Association of types of diabetes and insulin dependency on birth outcomes
Xaverius, P. K., Howard, S. W., Kiel, D. W., Thurman, J., Wankum, E., Carter, C., Fang, C., & Carriere, R. (2022) · World Journal of Clinical Cases · doi:10.12998/wjcc.v10.i7.2147 · Cited by 3
Sangtani, A., Owens, L. E., Broome, D. T., Gogineni, P., Herman, W. H., Harris, L. H., & Oshman, L. D. (2023) · Current Diabetes Reports · doi:10.1007/s11892-023-01512-4 · Cited by 2
Rendell, M. (2019) · Diabetes Obesity and Metabolism · doi:10.1111/dom.13836 · Cited by 2
“In highly planned pregnancies in diabetes patients, the goal prior to conception is to keep HbA1c as close to normal as possible to prevent excess spontaneous abortions and major congenital malformations.(13,14) Tight glycaemic control during the first trimester and throughout pregnancy is required to avoid maternal,…”
BackgroundDiabetes mellitus und Schwangerschaft
Schäfer-Graf, U. M., Kautzky‐Willer, A., & Groten, T. (2024) · Springer Reference Medizin · doi:10.1007/978-3-662-63506-3_26 · Cited by 1
Izewski, J. M., Peña, A., Tang, R., Crites, K., Campbell, M., Pelton, S., Saiko-Blair, M., & Scifres, C. (2025) · American Journal of Perinatology · doi:10.1055/a-2682-6382 · Cited by 1
Swiss Diabetes and Technology recommendations
Gastaldi, G., Bally, L., Burckhardt, M., Gamarra, E., Hauschild, M., Konrad, D., Lehmann, R., Piazza, C. D., Savet, M., Schwitzgebel, V., et al. (2025) · Swiss Medical Weekly · doi:10.57187/s.4632 · Cited by 1
Pregnancy Outcomes in Patients with Type 1 Diabetes Using Continuous Glucose Monitoring
McCloskey, S. M., Biggio, J., Morgan, J. A., Mussarat, N., Toppin, J. D., Sternlieb, S. J., Manuel, N. E., Juracek, K., Shu, S., Stone, J., et al. (2026) · American Journal of Perinatology · doi:10.1055/a-2781-7373 · Cited by 1
Fraser, R., & Farrell, T. (2011) · Elsevier eBooks · doi:10.1016/b978-1-4160-5908-0.00044-2 · Cited by 1
Malformations and Miscarriages in Diabetes in Pregnancy
Mathiesen, E. R., & Damm, P. (2010) · Wiley eBooks · doi:10.1002/9781444315196.ch14 · Cited by 1
Self-citationDiabetes mellitus und Schwangerschaft
Schaefer-Graf, U. M., & Kautzky‐Willer, A. (2011) · Springer eBooks · doi:10.1007/978-3-642-12974-2_21 · Cited by 1
Chandalia, H. B., & Thadani, P. (2016) · International Journal of Diabetes in Developing Countries · doi:10.1007/s13410-016-0467-8 · Cited by 1
“9 % has also been reported in other studies [67].”
ResultLuzolo, G. M., Beya, D. T., Numbi, D. K., Nyota, P. K., Ngandu, P. C., Sumbu, B. M.-M., Natuhoyila, A. N., Ngole, M. Z., Ilunga, G. N., Nkanga, M. N., et al. (2020) · Open Journal of Obstetrics and Gynecology · doi:10.4236/ojog.2020.1030034 · Cited by 1
“It appears from the numerous studies carried out on pregnant diabetics that high HbA1c values are directly associated with unfavorable pregnancy outcomes and particularly with the occurrence of preeclampsia [64] [65] [66] [67].”
BackgroundСукало, А. В., Prylutskaya, V. A., Иванова, Е. В., & Dzerkach, T. A. (2021) · Proceedings of the National Academy of Sciences of Belarus Medical series · doi:10.29235/1814-6023-2021-18-3-263-273 · Cited by 1
Maternale Erkrankungen in der Schwangerschaft
Fischer, T., Grab, D., Grubert, T. A., Hantschmann, P., Kainer, F., Kästner, R., Kentenich, C. R. M., Klockenbusch, W., Lammert, F., Louwen, F., et al. (2016) · Elsevier eBooks · doi:10.1016/b978-3-437-23752-2.00017-1 · Cited by 2
Neue Aspekte aus der S2e-Leitlinie: Diabetes bei Kinderwunsch – engmaschig überwachen
Füchtenbusch, M., Hummel, M., Battefeld, W., Bührer, C., Groten, T., Haak, T., Kainer, F., Kautzky‐Willer, A., Lechner, A., Meißner, T., et al. (2022) · Deutsches Ärzteblatt · doi:10.3238/persdia.2022.01.21.02 · Cited by 1
Elberry, A. A., Rabea, H., Mohsen, S. M., Mourad, A. M., & Kinawy, G. (2022) · International Journal of Pharmacy and Pharmaceutical Sciences · doi:10.22159/ijpps.2022v14i5.43598 · Cited by 1
Fay, E., Simmons, L. E., & BROWN, C. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-82823-9.00008-8 · Cited by 1
Preconception Care for Individuals with Diabetes
Mukherjee, S. M., Dawson, A., & Carey, K. M. (2023) · EMJ Diabetes · doi:10.33590/emjdiabet/10305435 · Cited by 1
Mit automatischer Insulindosierung durch die Schwangerschaft
Thomas, A. (2024) · Info Diabetologie · doi:10.1007/s15034-023-4910-x · Cited by 1
Helvacı, B. C., Candemir, B., Cinel, M., Hepşen, S., Canlar, Ş., Dağdeviren, M., & Çakal, E. (2025) · Turkish Journal of Diabetes and Obesity · doi:10.25048/tudod.1701369 · Cited by 1
Betreuung von Neugeborenen diabetischer Mütter
Bührer, C. (2015) · Elsevier eBooks · doi:10.1016/b978-3-437-22061-6.50353-0 · Cited by 1
Type 1 diabetes in pregnancy-Perinatal outcome with special reference to fetal macrosomia
Persson, M. (2012) · Figshare
Insulintherapie in der Schwangerschaft
Schäfer-Graf, U. M. (2014) · Der Diabetologe · doi:10.1007/s11428-013-1152-x
Maternale Erkrankungen in der Schwangerschaft
Beinder, E., Fischer, T., Grab, D., Grubert, T. A., Hantschmann, P., Kainer, F., Kästner, R., Kentenich, C. R. M., Klockenbusch, W., Kopp, R., et al. (2012) · Elsevier eBooks · doi:10.1016/b978-3-437-23751-5.10017-2
Albai, A., Șerban, V., Timar, R. Z., Vlad, A., Timar, B., Cristina, I., & Sdic, O. (2012) · Romanian Journal of Diabetes Nutrition and Metabolic Diseases · doi:10.2478/v10255-012-0028-y
Akute metabolische Entgleisungen
Maier, R. F. (2006) · Springer eBooks · doi:10.1007/978-3-540-33738-6_14
Infertilités endocriniennes féminines en dehors du syndrome des ovaires polykystiques
Chabbert‐Buffet, N. (2011) · Springer eBooks · doi:10.1007/978-2-8178-0061-5_16
Verier‐Mine, O., Dorey, F. J., Bacri, J.-L., & Quiquempois, H. (2012) · EMC - Endocrinologie - Nutrition · doi:10.1016/s1155-1941(12)40976-3
KNOWLEDGE, ATTITUDES AND PRACTICES RELATED TOPREGNANCYAMONG PREGNANT WOMEN IN SAMAR, PHILIPPINES.
IJAR, Tizon, M. M., Rosalia Prismarini, N., & IJAR (2016) · International Journal of Advanced Research · doi:10.21474/ijar01/705
Navathe, R. S., Gerli, S., Pacella, E., & Berghella, V. (2016) · Springer eBooks · doi:10.1007/978-3-319-31377-1_14
Mackeen, A. D., & Paglia, M. J. (2016) · CRC Press eBooks · doi:10.1201/9781315200910-5
(2022) · Dykinson eBooks · doi:10.2307/j.ctv2zp4w05.14
Metadata
- Authors
- Jensen, D. M., Korsholm, L., Ovesen, P., Beck-Nielsen, H., Moelsted-Pedersen, L., Westergaard, J. G., Moeller, M., & Damm, P.
- Affiliations
- University of Southern Denmark (DK)
- Aarhus University Hospital (DK)
- Department of Endocrinology, Odense University Hospital, University of Southern Denmark, Odense, Denmark;
- Department of Obstetrics and Gynecology, Copenhagen County Hospital, University of Copenhagen, Copenhagen, Denmark;
- Odense University Hospital (DK)
- Department of Obstetrics and Gynecology, Aalborg University Hospital, Aalborg, Denmark;
- University of Copenhagen (DK)
- Corresponding author
- Jensen, Dorte M.
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2009-03-05
- Volume
- 32
- Issue
- 6
- Pages
- 1046-1048
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- PMC
- PMC2681038
- OpenAlex
- W2108100082
- Cited by
- 227
- References
- 14
- Citations by year
- 2026: 8 · 2025: 7 · 2024: 13 · 2023: 14 · 2022: 22 · 2021: 16 · 2020: 24 · 2019: 14 · 2018: 18 · 2017: 12 · 2016: 16 · 2015: 11 · 2014: 9 · 2013: 7 · 2012: 11
- FWCI
- 13.01
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Diabetes Care (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- University of Southern Denmark Research Portal (University of Southern Denmark) (submittedVersion)
- Research at the University of Copenhagen (University of Copenhagen) (submittedVersion)
- Funders
- Diabetesforeningen
- Topics
- Health Sciences › Medicine › Obstetrics and Gynecology › Gestational Diabetes Research and Management
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Pregnancy and Medication Impact
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- type 1 diabetes, HbA1c, preconception care, pregnancy outcomes, congenital malformations, perinatal mortality, glycemic control
- MeSH terms
- Chromosome Aberrations, Diabetes Mellitus, Type 1, Female, Glycated Hemoglobin, Humans, Infant, Newborn, Pregnancy, Pregnancy Complications, Pregnancy Outcome, Prospective Studies, Retrospective Studies, Body Mass Index, White People, Perinatal Mortality
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.